No Data
Piper Sandler Upgrades Alignment Healthcare to Overweight From Neutral
Alignment Healthcare (ALHC) has an average outperform rating and a price target range of $4.50 to $10, according to analysts polled by Capital IQ. Price: 7.18, Change: +0.31, Percent Change: +4.51
Alignment Healthcare Price Target Raised to $8.00/Share From $6.00 by Piper Sandler
Alignment Healthcare Price Target Raised to $8.00/Share From $6.00 by Piper Sandler
Alignment Healthcare Raised to Overweight From Neutral by Piper Sandler
Alignment Healthcare Raised to Overweight From Neutral by Piper Sandler
Piper Sandler Upgrades Alignment Healthcare to Overweight, Raises Price Target to $8
Piper Sandler analyst Jessica Tassan upgrades Alignment Healthcare from Neutral to Overweight and raises the price target from $6 to $8.
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Crinetics Pharmaceuticals (CRNX) and Alignment Healthcare (ALHC)
Analysts Offer Insights on Healthcare Companies: Alignment Healthcare (ALHC), Butterfly Network (BFLY) and Deciphera Pharmaceuticals (DCPH)